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Cost of best-practice primary care 
management of chronic disease in a 
remote Aboriginal community
Abstract
Objective: To estimate the cost of completing all chronic care tasks 
recommended by the Central Australian Rural Practitioners Association 
Standard Treatment Manual (CARPA STM) for patients with type 2 diabetes and 
chronic kidney disease (CKD).
Design and setting: The study was conducted at a health service in a remote 
Central Australian Aboriginal community between July 2010 and May 2011. The 
chronic care tasks required were ascertained from the CARPA STM. The clinic 
database was reviewed for data on disease prevalence and adherence to CARPA 
STM guidelines. Recommended tasks were observed in a time-and-motion study 
of clinicians’ work. Clinicians were interviewed about systematic management 
and its barriers. Expenditure records were analysed for salary and administrative 
costs.
Main outcome measures: Diabetes and CKD prevalence; time spent on chronic 
disease care tasks; completion of tasks recommended by the CARPA STM; 
barriers to systematic care identiﬁ ed by clinicians; and estimated costs of 
optimal primary care management of all residents with diabetes or CKD.
Results: Projected annual costs of best-practice care for diabetes and CKD for 
this community of 542 people were $900 792, of which $645 313 would be met 
directly by the local primary care service. Estimated actual expenditure for these 
conditions in 2009–10 was $446 585, giving a projected funding gap of $198 728 
per annum, or $1733 per patient. High staff  turnover, acute care workload and low 
health literacy also hindered optimal chronic disease care.
Conclusion: Barriers to optimal care included inadequate funding and 
workforce issues. Reduction of avoidable hospital admissions and overall costs 
necessitates adequate funding of primary care of chronic disease in remote 
communities.
 The health of Australian Aboriginal and Torres Strait Islander people is very poor, 
and their access to primary care is 
inadequate, especially in remote 
areas.1-3 Prevalence of and mortal-
ity from type 2 diabetes (hereafter 
diabetes) and chronic kidney dis-
ease (CKD) are extremely high in 
remote Aboriginal communities in the 
Northern Territory.4 Chronic disease 
is responsible for 80% of the mortal-
ity gap between Indigenous and non-
Indigenous Australians, with diabetes 
accounting for 12%.5 For all Indigenous 
Australians, the self-reported preva-
lence of diabetes is more than three 
times, and the incidence of end-stage 
CKD six times, the non-Indigenous 
rates.3 In remote Aboriginal commu-
nities in the NT, CKD prevalence is 
up to 25% of the population,4 or 46% 
of adults.6 Diabetes prevalence is in 
the order of 13%7 to 16%4 of the pop-
ulation, or up to 29% of adults.6 Both 
conditions are major contributors to 
cardiovascular disease, the great-
est single contributor to the mortal-
ity gap.5
The origins of the chronic disease 
epidemic in Indigenous populations 
and, more broadly, the health gap 
are complex,3,6 and actions address-
ing both the social determinants of 
health3,4,7,8 and systematic primary 
clinical care6,9 are needed. In this 
study, we focused on the need for sys-
tematic clinical care, which is essential 
to reduce complications and delay the 
progression of diabetes and CKD.6,9
The rate of avoidable hospitalisa-
tions, a key marker of access to and 
effectiveness of primary care, is highest 
in remote communities.10 Australian 
and international evidence shows 
strong primary care systems result in 
better health outcomes, lower rates 
of avoidable hospitalisations, avoid-
ance of dialysis, and signifi cant cost 
savings.9-13 Many hospitalisations for 
complications of diabetes and CKD 
can be avoided through systematic pri-
mary care treatment, with signifi cant 
medical cost savings.10,13-15 However, 
there are few estimates of the resources 
required to sustain primary care man-
agement of these conditions.
Particular diffi culties for remote pri-
mary care include isolation, long dis-
tances to services, understaffi ng and a 
high turnover of clinical staff.16 Remote 
health care also requires special skills 
in chronic disease management, acute 
care, public health and intercultural 
communication.13,14,16,17
Our study was initiated by an 
Aboriginal community controlled 
remote health service because, despite 
its own perceptions of competent staff 
and clinical systems, staff still strug-
gled to satisfy existing clinical pro-
tocols within given resources. The 
service received funding primar-
ily from the then federal Offi ce for 
Aboriginal and Torres Strait Islander 
Health and the then NT Department 
of Health and Families. Other sources 
included Medicare and a small uni-
versity research grant. The aim of our 
study was to estimate the resources 
required by a remote health service 
to optimally manage diabetes and 
CKD — with adherence to the local 
Central Australian Rural Practitioners 
Association Standard Treatment 
Manual (CARPA STM) guidelines15 
and with full population coverage.
Methods
The study took place between July 
2010 and May 2011 in a remote Central 
Australian community. The methods 
were adapted from the models of care 
health service planning approach18 and 
an earlier NT cost study.10 Using the 
models of care approach, Segal and 
colleagues18 began with local best-
practice protocols and estimated the 
staff time required to complete each 
of the recommended tasks for a given 
population. The population health sta-
tus was assessed and the best-practice 
health care tasks required for that pop-
ulation were defi ned for each health 
profession involved. The time required 
per patient per year for each task was 
then determined, and the health care 
staffi ng resources then calculated for 
the population. Zhao and colleagues10 
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used an analogous approach to esti-
mate the total operating costs of a “rea-
sonably effi cient” remote Aboriginal 
health service. Population needs were 
defi ned in terms of the CARPA STM 
protocols.15 The time estimate given in 
the defi nition of each linked Medicare 
Benefi ts Schedule item was used in 
quantifying the population’s staffi ng 
needs.10
The target population was resident 
adults (> 18 years of age) with diabe-
tes or CKD. Best practice was defi ned 
in terms of the CARPA STM proto-
cols.15 These protocols are used by all 
NT primary care providers: govern-
ment clinics and Aboriginal commu-
nity controlled health services.19 The 
tasks recommended by the CARPA 
STM include history taking, health 
promotion, education, physical exami-
nation, biochemical investigations and 
prescription of medication.15
First, prevalence of diabetes and 
CKD was estimated using the health 
service electronic health record, which 
represents not only patients present-
ing for diabetes and CKD management 
but also those identifi ed in commu-
nity screening. Prevalence at multi-
ple levels of severity was estimated 
for both conditions. For CKD, levels 
of severity were stages 1–5 (estimated 
glomerular fi ltration rate range, > 90 
[stage 1] to < 15 mL/min/1.73 m2 [stage 
5]), with early CKD defi ned as stages 
1–3. For diabetes, early was defi ned 
as non-insulin-treated and advanced 
was defi ned as insulin-treated. This 
enabled us to calculate, at the commu-
nity level, the total annual number of 
diabetes and CKD care tasks recom-
mended by the clinical protocols.
Second, semistructured interviews 
informed two aspects of the study. 
Clinicians were asked to estimate 
the time required for each protocol 
task, as well as any unremunerated 
out-of-hours time essential for the 
chronic disease management program. 
Clinicians’ descriptions of their role in 
chronic disease care helped to struc-
ture the fi nal staff-funding model and 
also to identify other barriers to best-
practice care.
Third, the daily work and chronic 
disease consultations undertaken 
by a cross-section of clinicians were 
directly observed in a detailed time-
and-motion study. We measured the 
time taken by each clinician for each 
task defi ned by the relevant CARPA 
STM protocol. We then used a combi-
nation of these observations and inter-
view data to estimate an average time 
for each item (such as measuring blood 
pressure or discussing diet). Supplies 
were itemised for each protocol and 
costed using the clinic’s supply orders 
or representative prices.
Fourth, fi nancial records provided 
clinicians’ wage rates and adminis-
trative fi xed costs. The wage rates, 
together with the estimates of time-
per-task and annual community care 
requirements, were used to calculate 
the total cost of clinical staffi ng for pri-
mary care of diabetes and CKD.
We considered costs that, while non-
clinical, are part of the overall cost 
footprint of diabetes and CKD care. 
Using data from direct observation of 
clinicians’ workdays, we estimated the 
proportion of total clinical time spent 
on diabetes and CKD. This proportion 
was then applied in a top-down fash-
ion to the health service’s non-clinical 
costs, so that part of the cost of cleri-
cal staff and clinic vehicles was attrib-
uted to diabetes and CKD. These data 
collection and cost estimation meth-
ods are summarised in the Appendix 
(online at mja.com.au).
Finally, we compared the estimated 
2009–10 expenditure on diabetes 
and CKD with the projected annual 
expenditure using our best-practice 
model, refl ecting full protocol compli-
ance. For this, we assessed the level of 
clinicians’ adherence to the guidelines 
using the One21seventy health record 
audit tool, which is widely accepted in 
Indigenous health services in Australia 
and is based on the CARPA STM pro-
tocols.20 Per capita fi gures were calcu-
lated as total staff hours required for 
tasks specifi c to each group (eg, staff 
hours per patient per week to manage 
insulin treatment) divided by the num-
ber of patients with CKD or diabetes.
We distinguished between costs met 
out of the health service budget and 
expenses met directly by the federal 
and NT governments and other agen-
cies. Examples of the latter are med-
ications provided free to Indigenous 
patients under s 100 of the National 
Health Act 1953 (Cwlth), and visiting 
allied health services. The increased 
cost of such items in our model of care 
was separated from any additional 
funding needed by the health service 
to provide that model.
For comparison with the study by 
Zhao et al we adjusted the 2003–04 
NT-wide fi gures for infl ation occurring 
between fi nancial years 2003–04 and 
2009–10 (using the Consumer Price 
Index for health care in Darwin), and 
only included comparable aspects of 
1  Estimated 2009–10 and projected annual costs* for the primary care 




Remote health centre costs
Clinical staff 228 906 340 392
Remote area nurses and Aboriginal health workers 62 011 68 592
General practitioners 38 799 74 439
Chronic disease educators and visiting dietitians 128 096 197 362
Administrative staff 76 383 108 507
Medical supplies 4079 5795
Other operating costs 137 217 190 618
Maintenance 1240 1762
Vehicles 27 758 35 123
Other supplies 1635 2322
Other administrative (including computers, power) 106 584 151 411
Total 446 585 645 313
Direct costs to federal and NT governments† 234 424 255 479
Grand total 681 008 900 792
NT = Northern Territory. * Full coverage and full adherence to protocol. † Includes dental (NT), and 
optometry, non-vehicle and vehicle capital costs, and medications provided to Indigenous patients 
under s 100 of the National Health Act 1953 (Cwlth). 
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our study (eg, insulin treatment was 
excluded).10,21
Approval was received from the 
remote community’s health board 
and the Central Australian Human 
Research Ethics Committee (ref: 
2010.08.07). Written consent was 
obtained from all individual partic-
ipants. Verbal and written feedback 
was provided to the health board at 
the conclusion of the study.
Results
In this remote community with a 
population of 542, 519 (96%) were 
Aboriginal.22 Of the 297 adults, 74 
(25%) had diabetes and 86 (29%) had 
CKD; 45 (15%) had both conditions. 
Thirty-one adults (10%) had CKD 
stages 3–5. Of the 74 adults with diabe-
tes, 13 (18%) were prescribed insulin.
The clinic was staffed by four 
Aboriginal health workers (AHWs), 
three remote area nurses (RANs), a 
general practitioner, a chronic disease 
educator (CDE) and an exercise phys-
iologist. Twelve staff interviews were 
completed, and 14 workdays and seven 
clinical consultations were directly 
observed.
Quarterly chronic disease checks 
with an AHW or RAN were recom-
mended for most patients with dia-
betes or CKD. A GP reviewed clinical 
fi ndings and investigations, prescribed 
medication where necessary, and over-
saw treatment planning. A full-time 
CDE educated individual patients and 
groups and managed insulin treat-
ment. Interviewed staff identifi ed edu-
cation as crucial for patients’ control of 
their chronic disease. Locating patients 
in the community and delivering and 
explaining their medications were also 
a signifi cant part of clinicians’ work. 
According to the medical record audit, 
75% of all recommended protocol tasks 
for diabetes management and 79% 
for CKD were completed in 2009–10. 
Based on 2009–10 staffi ng, our model 
results in 29% of total clinical hours 
being used for diabetes and CKD care.
The total projected annual primary 
care cost of clinical management 
of diabetes and CKD management 
with full adherence to the protocols 
for all patients would be $900 792 
(Box 1). On average, the annual cost 
per patient would be $7856, ranging 
from $4062 (for people with previ-
ously dia gnosed early CKD without 
dia betes and without high cardiovas-
cular risk) to $15 241 (for people with 
stage 5 CKD and advanced diabetes, 
with a recent diagnosis of either con-
dition) (Box 2). Including only the costs 
met through the health service-allo-
cated budget, the projected cost to the 
centre would be $645 313, or $5628 per 
patient on average, based on estimated 
total annual direct clinical staff hours 
specifi cally for diabetes and CKD of 
4226 hours, or 2.37 full-time equiv-
alents. (The difference between the 
cost to the centre and the total pro-
jected annual cost consists of costs 
met directly by other sources, includ-
ing the federal and NT governments, 
rather than through the health service 
budget.) Expenditure in 2009–10 by the 
remote health service for diabetes and 
CKD care was estimated at $446 585, 
or $3895 per patient (Box 1). The health 
service would thus require an addi-
tional $198 728 (ie, an additional $1733 
per patient) for best-practice manage-
ment of diabetes and CKD. Overall 
funding received by the health cen-
tre in 2009–10 was $3413 per patient.
Interviews with staff identified 
a number of other barriers to opti-
mal care. The high turnover of RANs 
necessitated frequent intensive ori-
entation and teaching for new staff. 
The clinic was also rarely fully staffed. 
On-call night work, cross-cultural 
communication and cultural dif-
ferences can present diffi culties for 
RANs. AHWs may face a confl ict of 
duties and values between the com-
munity and the health centre and a 
heavy responsibility in the role. A 
high acute caseload and the reticence 
of many patients to attend checks, for 
reasons including low health literacy 
and long waiting times, also hinder 
adequate management of chronic dis-
ease. There is a perceived need to allow 
more time for clinicians and patients 
to build relationships and for commu-
nity-building work.
Discussion
Our study identifi ed a high prevalence 
of diabetes and CKD in a remote com-
munity. As this is the community’s 
only clinic and the community health 
screening coverage is high, the clinic-
based prevalence approximates popu-
lation prevalence and is consistent with 
other remote community studies.4,13
This service is relatively well funded 
compared with other NT primary care 
services. Expenditure in 2009–10 was 
$3413 per capita per annum. The mean 
per capita fi gure for NT Government 
remote clinics for 2011–12 was $2329. 
This service has a higher than average 
compliance with the protocols for CKD 
and diabetes (77%, compared with the 
2  Total projected annual costs per patient* for the primary care management 
of type 2 diabetes and chronic kidney disease (CKD) in a remote Aboriginal 
community, by stage of disease and comorbidity
Cost, by severity of CKD ($)
Condition and case type No CKD or stage 1–3 Stage 4 Stage 5†
CKD without diabetes
New cases 4345 4547 5200
Existing cases
Without high cardiovascular risk 4062 4175 5042
With high cardiovascular risk 4125 – –
Non-insulin-treated diabetes
New cases 4428 4601 5252
Existing cases
Without high cardiovascular risk 4133 4228 5093
With high cardiovascular risk 4196 – –
Insulin-treated diabetes
New cases 14 417 14 590 15 241
Existing cases
Without high cardiovascular risk 14 122 14 218 15 083
With high cardiovascular risk 14 185 – –
* Full coverage and full adherence to protocol. † Dialysis costs excluded. 
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territory-wide fi gure of 73% for clin-
ics participating in the One21Seventy 
audit). In response to low health liter-
acy and patient mobility, the clinicians 
engage in very active outreach, health 
education and opportunistic screen-
ing. Most remote communities do not 
employ a CDE or exercise physiologist.
Despite these positive factors, 
2009–10 expenditure was insuffi cient 
to provide optimal management by 
a margin of 44%, or an average of 
$1733 per patient with diabetes or 
CKD. Quantitative data were con-
sistent with clinicians’ perceptions at 
interview that additional staff mem-
bers were required to work with the 
CDE and AHWs to adequately meet 
community needs. Additional staff 
could increase the crucial quarantin-
ing of AHWs’ and RANs’ chronic dis-
ease care time from acute care time, 
possibly contributing to enhanced 
retention of staff. It would also allow 
greater allied health coverage, increas-
ing exposure of patients to consistent 
health messages, and additional infor-
mal staff education.
The costs calculated in our study 
were higher than the infl ation-adjusted 
(2003–04 to 2009–10) NT remote com-
munity estimates produced by Zhao 
et al.10,21 Possible reasons include the 
conservative estimates by Zhao et al of 
clinical time needed in remote health 
services for chronic disease care and 
staff training, and the higher admin-
istrative and salary costs at the stud-
ied remote clinic compared with those 
used in the earlier study.10
Strong primary care systems result 
in better health outcomes and sig-
nifi cant cost savings.9,11-13 There is a 
strong argument for adequate fund-
ing of primary care services like the 
subject of our study. Our fi ndings also 
highlight the lack of benchmarks that 
might indicate appropriate levels of 
funding to meet community needs and 
provide cost-effective care.
The strength of this study is its rig-
our and comprehensiveness, using 
multiple data sources (qualitative and 
quantitative). However, the methods 
are resource intensive and replication 
at other locations or with other dis-
ease groups would be expensive. Other 
limitations include the fact that costs 
were kept constant in our modelling. 
It is likely that unit and, possibly, fi xed 
costs will increase as 100% community 
coverage and adherence to protocols is 
approached. It may be that 100% cov-
erage and compliance is uneconomical.
Limitations to generalising these 
fi ndings to other remote Indigenous 
health centres are the wide variation 
in transport costs, the availability of 
allied health care, and the feasibility of 
indicated insulin treatment given lim-
ited staffi ng resources. The small sam-
ple size also means that caution must 
be taken in generalising the results.
Nevertheless, this community is 
not unrepresentative of many remote 
Indigenous communities, and our 
study provides the best available evi-
dence about the funding gaps for opti-
mal management of two prevalent 
chronic diseases in such communi-
ties. It documents a signifi cant short-
fall even in a relatively well funded 
and effective primary care service, 
close to the regional centre. We would 
expect that the documented shortfall 
is a conservative estimate. These fi nd-
ings should inform funding bodies in 
their allocation of health resources 
for remote Indigenous communities. 
It may also be of use to this and other 
remote communities in advocating for 
their health care needs.
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